NasdaqGM - Nasdaq Real Time Price
USD
Supernus Pharmaceuticals, Inc. (SUPN)
41.92
+0.08
(+0.19%)
At close: 4:00:00 PM EDT
41.92
0.00
(0.00%)
After hours: 4:05:40 PM EDT
Trade SUPN on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BARLOW CARROLEE Director |
Stock Award(Grant) | Feb 24, 2026 | 27,045 |
| BHATT PADMANABH P Officer |
Conversion of Exercise of derivative security | Aug 12, 2026 | 18,637 |
| DEC TIMOTHY C Chief Financial Officer |
Conversion of Exercise of derivative security | Aug 12, 2026 | 9,129 |
| GEMAYEL GEORGES PH.D. Director |
Sale | Mar 6, 2026 | 27,277 |
| HUDSON FREDERICK M Director |
Sale | Mar 12, 2026 | 60,413 |
| KHATTAR JACK A Chief Executive Officer |
Conversion of Exercise of derivative security | Aug 12, 2026 | 2,216,450 |
| MOTTOLA FRANK Chief Technology Officer |
Conversion of Exercise of derivative security | Aug 12, 2026 | 19,544 |
| NEWHALL CHARLES W III Director |
Stock Award(Grant) | Feb 24, 2026 | 124,119 |
| RUBIN JONATHAN Officer |
Conversion of Exercise of derivative security | Aug 12, 2026 | 13,979 |
| SENSENIG BETHANY Director |
Sale | Feb 19, 2026 | 0 |
